All In Biotech

Free tool

FAERS Monitor: Doxil (Liposomal)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050718 or its brand name (Doxil (Liposomal), Doxorubicin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

32,988

Serious

30,133

91% of reports

Hospitalization

12,409

Death reported

5,456

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use3,874
  • febrile neutropenia3,562
  • neutropenia2,221
  • pyrexia1,828
  • disease progression1,808
  • product use in unapproved indication1,758
  • nausea1,651
  • anaemia1,539
  • alopecia1,533
  • vomiting1,328
  • thrombocytopenia1,270
  • diarrhoea1,156
  • pneumonia1,103
  • fatigue1,083
  • hair colour changes1,080

Reports by year received

View as table
YearReports
2004365
2005434
2006431
2007531
2008576
2009364
2010392
2011590
2012769
2013589
2014466
20151,241
20161,079
20171,587
20181,975
20192,308
20203,545
20212,306
20223,066
20233,284
20242,933
20252,386
20261,771

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,171 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hair colour changesSignal1,08060.556.957,690
febrile neutropeniaSignal3,56236.135.0115,445
neutropeniaSignal2,22110.610.219,046
disease progressionSignal1,8089.99.414,278
thrombocytopeniaSignal1,2707.36.96,873
anaemiaSignal1,5395.24.95,190
alopeciaSignal1,5335.04.84,922
product use in unapproved indicationSignal1,7584.54.34,885
pyrexiaSignal1,8283.43.23,097
off label useSignal3,8742.82.74,757
pneumoniaSignal1,1032.22.1709
vomiting1,3281.81.7484
nausea1,6511.31.3140
diarrhoea1,1561.11.121
fatigue1,0830.90.816

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.